Connect with us

Business

Third member of US FDA advisory panel resigns over Alzheimer’s drug approval – Fox Business

Published

on

Article feature image
ADVERTISEMENT

A third member of a panel of outside advisers to the U.S. Food and Drug Administration has resigned in protest over the agency’s decision to approve Biogen Inc’s Alzheimer’s disease treatment despite the committee’s recommendation against doing so.
Aaron…

Click here to view the original article.

Continue Reading
Advertisement

You might also like ...

Article feature image
Branson’s Virgin Orbit in talks with former Goldman partner’s SPAC for $3 billion deal to go public – CNBC
Sold! Bidder pays $28m for spare seat on space flight with Jeff Bezos – The Guardian
Article feature image
Jay Leno Attempts Quarter-Mile Record In Tesla Model S Plaid – Motor1